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It is now  widely accepted that  the interaction of exogenous pyrogens,  such 
as  bacteria or  bacterial products,  with  host  phagocytic cells,  activates  these 
cells  to  release  a  protein  which  stimulates  the  hypothalamus  and  results  in 
fever (1). This protein is called endogenous or leukocytic pyrogen and is con- 
sidered to be the mediator of a wide variety of clinical and experimental fevers. 
Although it has not been convincingly demonstrated in vivo in human beings, 
leukocytic pyrogen can readily be produced in vitro from human  blood leuko- 
cytes (2, 3). It is known that, in addition to being a protein, this pyrogen has a 
mol wt of approximately 13,000 (4). Both human and rabbit leukocytic pyrogen 
will result in febrile responses in rabbits and have similar characteristics. Con- 
siderably  more  is  known  about  the  molecular  nature  of  rabbit  leukocytic 
pyrogen (5-7) than about the human material (4, 8, 9). 
During the course of purifying and characterizing human leukocytic pyrogen 
we observed that human blood leukocytes produce two distinct molecules with 
pyrogenic properties. One  of  these pyrogens is derived from peripheral blood 
monocytes and the other from neutrophils. The present report describes some 
of the biological and chemical properties of the two pyrogens. 
Materials and Methods 
Materials.--All needles, syringes, glassware, media, and solutions were sterile and pyrogen- 
free. 
P~rogen Assay.--New  Zealand albino rabbits of either sex from the National Institutes of 
Health colony and weighing 2-3 kg were used  throughout. The details of housing,  feeding, 
training, and temperature recording were as previously reported (3, 10). A rise of less than 
0.3°C was not considered significant. Temperature data presented are derived from mean re- 
sponses. Rabbits were occasionally injected twice in a day (morning and afternoon).  All in- 
jections were given intravenously into a lateral ear vein. 
Leukocfles.--Buffy coat concentrates from 450 ml of fresh ACD (Transfer Pack, Fenwall 
Laboratories, Monroe Park, Ill.) whole human blood were obtained after eentrifugation at 
1,500 g for 3 min. The plasma was removed and discarded. The upper 50-75  ml of red cells 
were either sedimented in 3% dextran (mol wt 200,000) (Sigma Chemical Co., St. Louis, Mo.) 
in physiologic saline  or separated on a  Ficoll-Hypaque (Ficoll, Pharmacia Fine Chemicals, 
Inc., Uppsala, Sweden; Hypaque, Winthrop Laboratories, New York)  gradient (11) in 50-ml 
conical centrifuge  tubes. Another source of leukocyte preparations was blood remaining in the 
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pump oxygenator apparatus following cardiopulmonary by-pass operations. Such blood was 
sedimented in 4.5% dextran and the red blood cells were removed by hypotonic lysis. Total 
white  blood cell  counts were  done  in  an  electronic particle  counter  (Coulter  Electronics, 
Hialeah, Fla.). Differential counts (300 cells) were done on Wright's stained smears on slides 
prepared in a cytocentrifuge (Shandon Scientific, Sewicley,  Pa.). 
Preparation of Leukocytic Pyrogen.--20 million total white blood cells were suspended per 
ml of Hank's balanced salt solution (HBSS) with 100 U of penicillin G, 2 U of heparin and 
8 pg of gentamicin per ml. AB serum which had been stored at --70°C was added to make 
a  final concentration of  10%.  Heat-killed Staphylococcus albus was  added  to  make a  final 
bacteria:leukocyte ratio of  30:1  (3).  Suspensions were  then placed in a  shaking incubator 
(American Optical  Corp.,  Richmond,  Calif.)  at 37°C  for 30 min and  centrifuged at  1,000 
rpm for 10 rain to remove S. albus and snpernatant serum. Cell pellets were resuspended  in 
fresh serum-free HBSS to make a final concentration of 5 million cells per ml and incubated 
18 h  at 37°C.  Following incubation, suspensions were  spun at 3,000 rpm  for 30 min. The 
supernate was removed and stored at 4°C in 0.02% sodium azide. 
Concentration Procedures.--Crude pyrogen lost significant activity when concentrated by 
filtration under positive pressure. Some preparations were dialyzed in cellulose tubing (Union 
Carbide Corp.,  Chicago,  Ill.)  against 20  volumes of cold water,  lyophilized, and  stored  at 
--20°C until used. Other preparations were dialyzed and then evaporated using a high speed 
fan at  room  temperature.  With the latter technique,  the  temperature of  the liquid during 
evaporation was approximately 12°C, and it was subsequently noted that this method yielded 
the best recovery of pyrogenic activity. 
Alcohol Precipitation.--Crude  pyrogen preparations were  precipitated  by  slowly  adding 
99% ethyl alcohol at  --10°C  under constant magnetic stirring. After 18 h  at  --20°C,  the 
precipitates were spun at 5,000 rpm (--10°C) for 30 rain. The supernatant solutions were dis- 
carded and the precipitate pellets resuspended in saline, distilled water, or buffers. The sus- 
pensions were vigorously pipetted until dissolved and then centrifuged at 10,000 rpm for 30 
min. These supernates were pyrogen tested in rabbits. Using eight rabbits, a  two-point dose- 
response curve was obtained before and after alcohol precipitation to determine loss of activity. 
Gel  Filtration.--All  columns  were  siliconized  and  autoclaved.  The  various  sizes  of  the 
columns are presented in the text. Sephadex (Pharmacia Fine Chemicals) was autoclaved in 
the  buffers for 30 rain before packing.  Gel filtration was  downward  and  the material was 
moved  either by  pump  (Extracorpeal  Medical  Specialties,  Inc.,  King  of  Prussia,  Pa.)  or 
Mariotte flask. The sterility and pyrogen-free nature of the columns, buffers, and Sephadex 
were verified by trial runs before application of pyrogen. Protein was determined either by 
optical density at 280 m# or by the method of Lowry, et al. (12). 
Isodectric Focusing.--The  techniques described by Radola (13)  and Felgenhauer and Pak 
(14)  were  modified  for semipreparative isoelectric focusing.  30-40  ml  of  salt-free pyrogen 
preparations  (either concentrated or partially purified)  were  slowly mixed with 2.5-3  g  of 
dry superfine Sephadex G-75. Ampholines (LKB Instruments, Bromma, Sweden) were added 
to make a  final concentration (wt/vol) of 2% of the total swollen Sephadex-sample mixture. 
After 2.4 h  at room temperature, the swollen gel was poured onto glass plates (20 em  X  10 
cm) and air dried until the edges began to recede. 
Electrode contact was made with wet filter paper applied to the 10 X  0.5 cm surface edge 
of the swollen gel. The plate was placed on a cooling block (Desaga, Heidelberg, Germany), 
maintained at 4°C and 400 V were applied through electrode baths (0.5% H3PO4 and 0.75% 
NaOH).  After 24 h, the paste-like Sephadex was scraped into 10 cm  X  1 cm strips and sus- 
pended in 2 ml of distilled water. 2 h later, pH was determined (Model 320, Fisher Scientific 
Co., Fair Lawn, N. J.). After pH measurement, the samples were further eluted in 10 ml of 
0.85% saline, mixed thoroughly, and centrifuged at 1,000 rpm for 5 min. Supernatant fluids 
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Neuraminidase.--A nonpyrogenic preparation of recombinant equine influenza neuramini- 
dase was tested for its ability to liberate siaiic acid during each experiment using the technique 
of Warren (15). 
RESULTS 
Dose-Response Assay of Monocyte  and Neutrophil Preparations.--Buffy coat 
concentrates separated in 3 % dextran contained a mixture of both neutrophils 
and monocytes. On the other hand, buffy coat concentrates separated from a 
Ficoll-Hypaque gradient had significantly greater numbers of monocytes and a 
marked decrease in the number of neutrophils. The latter preparations, although 
not pure,  were  labeled  "monocytes." In  contrast,  leukocytes obtained after 
dextran sedimentation o[ blood obtained from pump oxygenators had signifi- 
cantly fewer monocytes (P  <  0.01,  Student's t test). These preparations were 
labeled "neutrophils." The differential counts for these preparations are given 
in Table  I.  In  considering pyrogen producing cells,  the  lymphocyte can  be 
discarded, since it has been shown that these cells do not produce pyrogen (3). 
All  cell  preparations  were  stimulated under  the  same  conditions and  the 
supernatant fluids injected into rabbits. Fig. 1 depicts the dose-response curves 
for each of the  three preparations.  All fevers were monophasic with a  peak 
between 48 and 60 min following injection. Following heating (80°C for 15 min), 
all preparations became nonpyrogenic. As can be seen, monocytes release ap- 
proximately 20 times more pyrogen per cell than neutrophils. These data con- 
firm other previously reported data on pyrogen release from human monocytes 
(16). 
Gel Filtration of Crude Human Pyrogen.--Initially,  pyrogen obtained from 
buffy coat concentrates  (containing approximately 68 %  neutrophils and 5 % 
monocytes) were lyophilized, then reconstituted in 0.85 % phosphate-buffered 
saline  (pH  7.4),  and  placed on a  Sephadex G-50  column. The main protein 
peak was associated with the void volume. A single pyrogen peak was obtained, 
TABLE  I 
Differential  Counts of Blood Separated by Various Technifues 
Separation technique  Neutrophils  Monocytes  Lymphocytes  Eosinophils 
Dextran sedimentation  68.3  q-  3.0[]  5.0  -4-  0.4  26.0  ±  3.1  1.7  ~  0.4 
(3%)* 
Ficoll-Hypaque:~  15.3  -4-  3.2  22.0  ±  0.5  62.6  -4-  4.7  0.0 
Dextran sedimentation  71.1  4-  4.9  1.4  ±  0.5  25.2  :~  4.3  1.2  q-  0.4 
(4.5%)§ 
* Cells obtained from whole blood and data derived from nine separate experiments. 
:~ Cells obtained from whole blood and data derived from six separate experiments. 
§ Cells obtained from blood from pump oxygenator and data derived from eight separate 
experiments. 
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1.4 
which was separate from the protein (Fig. 2). This single pyrogen peak at the 
same elution volume was  confirmed several  times in different buffers  (0.5  iV[ 
Na acetate.  )H 4.5; 0.85% NaC1, pH 6.8; 0.85% NaCI in 0.007  M  KH2PO4, 
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FIG.  1.  (A) Dose-response curve of supernatant pyrogen from either neutrophil prepara- 
tions (O--O) or neutrophils and monocytes (O ..... O). See text. Each point represents the 
mean fever above baseline (AT) -4- SEM of 6-12 separate injections. (B) Dose-response curve 
of supernatant pyrogen from monocyte preparations  (e---Q).  Each point represents the 
mean fever above baseline (AT) +  SEM of 6-10 separate injections. C. A.  DINARELL0,  N.  P. GOLDIN,  AND  S. iV[.  WOLFF  1373 
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FIG. 2.  Median pyrogen peak  of  13  separate  chromatography experiments using con- 
centrated  leukocytic pyrogen derived from whole buffy coat  leukocytes. Sephadex G-50 
(coarse); column, 105  X 3.8 cm; solvent, 0.85% NaCI at pH 6.8; flow rate, 60 ml/h;  each 
fraction, 6.2 ml; sample size, 13.0 ml. Each fraction was injected into three rabbits.  (  ), 
protein; (-----), change in temperature (AT) above baseline in °C. 
pH 7.4; 1.6 % NaC1, 1% casein acid hydrolysate, pH 6.5) (Sigma Chemical Co.). 
Losses o[ approximately 50-60% occurred regularly during gel filtration; how- 
ever, the addition of casein acid hydrolysate (1%) reduced the loss to 20%  (7). 
Using ovalbumin, chymotrypsinogen, and  cytochrome c as known standards, 
the tool wt of the pyrogen peak was repeatedly in the 15,000  range. 
Isoelectric Focusing  of Crude and Column-Purified  Pyrogen.--Crude pyrogen 
from buffy coat  concentrates was dialyzed,  lyophilized  and  then  focused for 
18-24 h. A double pyrogen peak was occasionally seen. The main peak occurred 
at pH 6.8 and a minor one at pH 5.1  (Fig. 3). When crude pyrogen prepared 
from  monocytes  obtained  from  Hypaque-Ficoll  gradients  was  focused,  the 
main peak shifted to pH 5.1  and the minor peak was now at pH 6.8. However, 
when  pyrogen  effluents from gel  filtration  on  Sephadex  G-50  were  focused, 
only a single peak occurred at pH 6.9 (Fig. 3). 
Gel Filtration of Crude  Monocyte  Pyrogen.--Since  crude  pyrogen  obtained 
from suspensions of primarily monocytes seemed to increase the peak focused 
at pH 5.1, crude monocyte pyrogen was chromatographed on Sephadex G-50. 
Large  quantities  of  monocytic pyrogen  were  prepared  and  concentrated  by 
dialysis  and  evaporation.  A  single  run  through  the  Sephadex  G-50  column 
showed a broad peak immediately after the void volume. In order to determine 
the molecular weight of this peak, crude monocyte pyrogen was applied  to a 
G-75 (fine) Sephadex column (60 cm X  2.6 crn) and a double peak was present 
in 0.85 % phosphate-buffered saline at pH 7.4. In addition, a similar run in 6 M 
urea, 0.03 M  KH2PO~, pH 7.8, did not change the elution volume of the double 1374  HUMAN  LEUKOCYTIC  PYROGENS 
peak in relation to known standards. Fig. 4 shows the approximate mol wt for 
crude  monocyte  pyrogen  chromatographed  on  G-75 Sephadex.  The  larger 
pyrogen is about 38,000 while the smaller pyrogen is approximately 15,000. 
In order to separate the two pyrogen peaks, a longer (165  X  5.6 cm) column 
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F1o. 3.  Median pyrogen peaks from different pyrogen preparations after isoelectric focus- 
ing. The solid straight  line represents the pH gradient.  Febrile responses: (e--O), crude 
pyrogen from buffy coat concentrates;  (e---O),  crude pyrogen from monocyte  prepara- 
tions; (I  .....  i), G-50 pyrogen peak from buffy coat supernates. All points are  the  mean  of 
3-4 injections and the median curves are taken from not less than three experiments. Voltage, 
400 X 24 h. See text. 
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was made (Glass Shop, NIH). A typical run of concentrated crude monocytic 
pyrogen through Sephadex  G-50 is shown in Fig. 5. Although the two peaks 
were clearly separated,  up to 80% of the biologic activity of the crude mono- 
cytic pyrogen was  lost.  Both peaks  produced monophasic  fevers  and  after 
heating for 15  min at 80°C they lost  their pyrogenicity. However,  the large 
molecular  weight pyrogen produced  a mean fever peak at approximately 57 
min after injection  into rabbits while the smaller molecule attained a  mean 
peak at 41 min (Fig. 6). Using paired samples in the same rabbit, this difference 
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FIG.  5.  Median pyrogen peaks  of four chromatography experiments using concentrated 
crude monocyte pyrogen. Sephadex G-50 (fine); column, 165 X  5.6 cm; solvent, 0.850/0 phos- 
phate-buffered NaC1 in 1% casein hydrolysate at pH 7.4; flow rate, 120 ml/h; each fraction, 
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FIG.  6.  Mean  temperature  elevation  (4-  SEM)  of  0.6°C  from  baselines of  six  rabbits 
injected with the 38,000 mol wt pyrogen (  ..... )  and six rabbits injected with the 15,000 tool 
wt pyrogen (  ) purified by gel filtration. 1376  HUMAN  LEUKOCYT~  PYROGENS 
was significant (P  <  0.05,  t  test).  In addition,  the return of temperature to 
normal following the 38,000 mol wt pyrogen was slower than with the 15,000 
mol wt pyrogen (Fig. 6). Following repeated daily doses of the 38,000 tool wt 
pyrogen, the febrile responses remained unchanged. 
After  treatment  with  neuraminidase,  both peaks  retained  their  biological 
activity.  In  addition,  crude  monocytic pyrogen treated  with  neuraminidase 
for 2 h eluted at the same volume after gel filtration as untreated preparations. 
Isoelectric Focusing of Monocytic  Pyrogen.--Crude  monocytic pyrogen was 
concentrated and chromatographed on a  G-50 Sephadex column (165  X  5.6 
cm) in the presence of 1% casein hydrolysate (1.6% NaC1, pH 6.5). The large 
mol wt pyrogen peak (38,000) was isolated, concentrated by evaporation, and 
dialyzed. This material was then focused on thin layer Sephadex G-75 for 24 h. 
This  column-purified pyrogen molecule focused at  pH  5.21  and  corresponds 
to the crude pyrogen with pI  =  5.15.  A  column-purified preparation focused 
at the same pH even after treatment with neuraminidase. 
Other Characteristics of the Two Pyrogens.--Crude pyrogen preparations were 
precipitated  in  various  concentrations  of  ethyl  alcohol  at  --10°C.  75%  of 
neutrophil or buffy coat pyrogen activity was recovered from the precipitates 
which formed at a final alcohol concentration of 50-70 %  (vol/vol). Monocyte 
pyrogen preparations, on the other hand, lost 70-75 % of the activity at these 
same concentrations of alcohol and no activity was recovered at other concen- 
trations. Furthermore, no monocyte pyrogen activity was present in the alcohol 
soluble  compartment. The  alcohol was  removed by  dialysis before injection 
into rabbits. 
Alkaline dialysis for 24-48 h in Tris-HC1 0.05 M, pH 9.0, 4°C did not reduce 
the  pyrogenic activity of any of the  three  crude preparations.  Occasionally, 
crude monocytic pyrogen  lost  approximately  50%  of its  pyrogenic activity 
after dialysis against 0.05  M  PO4, pH 5.5,  4°C or Na acetate 0.5  M, pH 4.5, 
4°C. Although crude pyrogen preparations from monocytes were occasionally 
acid labile, the large molecular weight pyrogen isolated  after G-50 Sephadex 
gel filtration was always stable in acid. Crude neutrophil or buffy coat pyrogen 
as  well  as  isolated  small  molecular weight  pyrogen never lost  activity  with 
acid exposure at 4°C or 37°C. 
All three crude preparations as well as both pyrogen peaks isolated from the 
Sephadex G-50 columns were nonpyrogenic after heating at 80°C  for 15 min 
or incubating with  trypsin at pH  7.8 for 1 h  at 37°C.  The characteristics of 
the two pyrogens are summarized in Table II. 
DISCUSSION 
The present  experiments establish  the  existence of a  new,  previously  un- 
recognized,  pyrogen  which  is  released  from  human  blood  monocytes.  The 
monocyte pyrogen molecule is a larger and more acidic protein than neutrophil 
pyrogen.  As  demonstrated,  there  are  other  chemical  and  biological  charac- C.  A.  DINARELLO, N.  P.  GOLDIN, AND  S.  M.  WOLFF 
TABLE II 
Characteristics of Neutrophll and Monocyte Pyrogen 
1377 
gg protein/ml (crude)* 
#g protein/AT 0.6°C§ (crude) 
Mol wt (crude) 
Isoelectric  point  (chromato- 
graphed or crude) 
Precipitation and recovery from 
50% alcohol (crude) 
Mean fever peak in minutes (chro- 
matographed pyrogen) 
Inactivation by trypsin (crude or 
chromatographed) 
Inactivation at 80°C X  15  min 
(crude) 
Inactivation  by  neuraminidase 
(chromatographed  pyrogen) 
Change  in  pI  or  mo]  wt  after 
treatment  by  neuraminidase 
(chromatographed pyrogen) 
Inactivation after alkaline dialy- 
sis (crude) 
Decreased activity during storage 
at  4°C  (crude  or  chromato- 
graphed) 
Neutrophil pyrogen  Monocyte pyrogen 
Crude:[:  =  248  4-  18  (8) 
Crude  =  1,783  4-  200  (8) 
15,000 
6.92  4-  0.09  (14) 
Yes  (18) 
41.0  4-  2.0  (12) 
Yes  (9) 
Yes  (10) 
No  (5) 
No  (2) 
No  (4) 
No 
Crude  =  51  4-  17  (5) 
Crude  =  41  4-  16  (5) 
38,000 
5.14  4-  0.05  (8) 
No  (7) 
57.0  4-  4.0  (12) 
Yes  (4) 
Yes  (6) 
No  (5) 
No  (2) 
No  (3) 
Yes 
(after 4 mo)  (after 24--48 h) 
* The number in parenthesis indicates the number of observations; the words  indicate 
the particular preparations. 
:~ All crude preparations were made from 5 X  106 total white blood cells/ml of buffer. 
§/zg of protein required to elicit a temperature rise of 0.6°C. 
teristics which distinguish it from neutrophil pyrogen. In a previous report, no 
distinction was  made  between  the  elution peak  of monocyte  or whole  white 
blood  cell preparations  following  chromatography  on  Sephadex  G-75  (4).  In 
the  present  study,  a  distinct  separate peak  was  not  observed until  a  longer 
column  was  employed for gel filtration, which  may  in  part  explain why  this 
molecule was not recognized earlier. 
Some of the other reasons which might explain why the monocyte pyrogen 
molecule  was  not  previously detected  are:  (a)  the  molecule  is  unstable  and 
undergoes rapid degradation; (b) the molecule might be a dimer or other combi- 
nation of neutrophil pyrogen with  carrier protein;  and  (c)  monocyte pyrogen 
production  is  either  suppressed  or destroyed during  incubation  with  neutro- 
phils.  It  is  clear  from  these  investigations  that  crude  monocyte  pyrogen  as 
well as that purified by gel filtration loses activity during storage at 4°C, while 
comparable neutrophil pyrogen preparations do not. It is highly unlikely that 1378  HUMAN  LEUKOCYTIC  PYROGENS 
the  monocyte pyrogen  molecule  is  a  dimer  of neutrophil  pyrogen  since  the 
pI's of the two pyrogens are almost two pH units apart and the size of such a 
dimer would be smaller than the size of monocyte pyrogen. Furthermore,  the 
elution volume of the monocyte pyrogen did not change during gel filtration in 
6 M  urea, which should have separated a dimer. There is the possibility that a 
pyrogenic moiety similar to neutrophil pyrogen is attached to a nonpyrogenic 
parent protein from monocytes. Attempts to separate these two proteins with 
high solute concentrations  and isoelectric focusing failed. Yet we cannot rule 
out the possibility that the monocyte pyrogen molecule requires an enzyme to 
separate it  into  smaller units,  i.e.,  similar  to  the  size of neutrophil  pyrogen. 
Although unlikely, we have not excluded the latter possibility. 
Although  the  monocyte releases at  least  20  times more pyrogen  than  the 
neutrophil, it is unlikely that it contributes this order of magnitude of pyrogen 
in the buffy coat incubations since the 38,000 tool wt pyrogen peak was absent 
from  repeated  chromatographed  crude  pyrogen  preparations  In  fact,  it  is 
possible that 5 % of monocytes in the buffy coat incubations do not contribute 
to the pyrogenic activity of the crude pyrogen derived from such an incuba- 
tion  The presence  of such  large numbers  of neutrophils  in  these  buffy coat 
preparations may have a suppressive effect on monocytes to release endogenous 
pyrogen.  In support  of  this  concept,  is  the fact  that human huffy  coat  cells 
release more pyrogen when the supernatant medium is changed (3). The possi- 
bility  that the presence of large numbers of neutrophils suppresses monocyte 
pyrogen  release  may  help  clarify  an  unexplained  observation  in  the  patho- 
genesis of fever induced by antigen-antibody complexes. Despite the fact that 
antigen-antibody complexes infused in vivo cause fever (17), release of endog- 
enous pyrogen from buffy coat cells stimulated  with  such  complexes has not 
been demonstrated in  vitro)  Since  the monocyte may play a  key role in  the 
pathogenesis of this immune fever, the large number of neutrophils present in 
the preparations tested in vitro may account for the seeming failure to demon- 
strate the pyrogen in vitro. 
In order to test for sialic acid residues, which might have accounted for the 
acidic nature or large size of the monocyte pyrogen, the molecule was treated 
with neuraminidase. Following this treatment, there was no loss of activity or 
change in molecular size or isoelectric point. 
The fact  that  both human  as well  as  rabbit  endogenous pyrogen produce 
the same type of fever pattern in rabbits does not necessarily mean that both 
molecules are similar. Until the present studies, both human and rabbit pyro- 
gens were thought to be the same size (4). Most of the  chemical characteriza- 
tion and purification of rabbit endogenous pyrogen has been done on material 
derived from peritoneal exudate granulocytes (5-7). On the basis of the present 
experiments,  it  would  appear  that  there  are  significant  differences  between 
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rabbit and human leukocyte pyrogen when one compares the rabbit with the 
neutrophil pyrogen of man.  Human neutrophil pyrogen has  a  slightly larger 
molecular weight than the rabbit. The human pyrogen is a more acidic protein 
than the rabbit and is alkaline resistant while the rabbit is not. Human and 
rabbit pyrogen has been compared and it was found that human pyrogen is 
alkaline resistant (4). 
The fact that human monocyte and neutrophil pyrogens differ biologically 
may have important implications. The monophasic fevers that were produced 
by the 38,000 mol wt pyrogen had a  peak elevation at about 60 min,  while 
the 15,000  mol wt pyrogen had its peak temperature elevation at 36-48 min. 
The time of onset of both pyrogens was approximately 12-18 min following 
injection. Defervescence following the partially purified monocyte pyrogen was 
also slower than that of neutrophil pyrogen. It is possible  that  two different 
hypothalamic sites act as receptors for the two molecules and may explain the 
difference in fever curves. Furthermore, the larger molecule may exert its effect 
or be present in the circulation for a longer period of time. The cause of these 
differences, however, awaits further investigation. 
The demonstration of two distinct pyrogens from human white blood  cells 
should stimulate further investigations into the pathogenesis of fever in man. 
With improved techniques of isolation, we now may be able to begin to charac- 
terize and investigate the biological and physiological properties of these potent 
and potentially important materials. 
SUMMARY 
Human m0nocytes and neutrophils were separated from buffy coats of blood 
obtained from normal donors. Following incubation with heat-killed staphylo- 
cocci, monocyte preparations contained 20  times more pyrogenic activity in 
the supernatant media than did supernates from an equal number of neutro- 
phils. During purification of these pyrogens it was discovered that  these cell 
preparations each produced a distinct and different pyrogen. The pyrogen ob- 
tained from neutrophils had a tool wt of 15,000  following Sephadex G-75 gel 
filtration, an isoelectric point of 6.9, and could be precipitated and recovered 
from 50% ethanol at --10°C. In contrast, the pyrogen derived from monocyte 
preparations had a tool wt of 38,000, an isoelectric point of 5.1, and was de- 
stroyed in cold ethanol. Both molecules were unaffected by viral neuraminidase 
but biologically destroyed at 80°C for 20 rain and with trypsin at pH 8.0. The 
febrile peak produced by partially purified neutrophil pyrogen occurred at 40 
rain while that from monocytes was at 60 min. In addition, monocyte pyrogen 
produced  more  sustained  fevers for  the  same  peak  elevation  as  neutrophil 
pyrogen.  These  studies  demonstrate  for  the  first  time  two  chemically  and 
biologically distinctive pyrogens derived from circulating human white blood 
ceils and have important implications for our understanding of the pathogene- 
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Addendum.--Since  there  had  been  no  attempt  to  separate  lymphocytes  from 
monocytes when obtaining pyrogen from the "monocyte preparations," the possibility 
exists that lymphocytes might play an essential role in the release of pyrogen from 
monocytes  or  that  lymphocytes themselves release  the  larger pyrogenic molecule. 
Therefore,  further  experiments  were  performed  to  investigate  these  possibilities. 
Monocytes were prepared by allowing them to adhere to plastic surfaces and after 45 
rain were washed twice. These plastic adherent cells were then stimulated in the usual 
fashion with heat-killed S. albus and the supernatant fluid harvested after 18 h of in- 
cubation.  This  supernate  was  concentrated  and  passed  through  a  Sephadex  G-50 
column. A peak of pyrogenic activity at the same elution volume as the 38,000  tool 
wt monocyte pyrogen was found. Thus, these experiments suggest that the lympho- 
cyte is not the source of pyrogen and that they are not playing a role in the production 
or release of pyrogen from mixed monocyte-lymphocyte preparations in the present 
investigations. 
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